Beta Cell Biology Consortium (U01)
The summary for the Beta Cell Biology Consortium (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Beta Cell Biology Consortium (U01): The National Institute of Diabetes and Digestive and Kidney Diseases invite new U01 applications to participate in a consortium of investigators and institutions, the Beta Cell Biology Consortium (BCBC); http://www.betacell.org. The BCBC will work collaboratively to generate resources that will facilitate research to 1) understand how endogenous beta cells are made by studying pancreatic development, with the hope of making pancreatic islets in culture 2) explore the potential of animal and/or human stem cells (embryonic or adult; if human embryonic, only NIH approved hES cell lines may be used) as a source for making pancreatic islets, and 3) determine the basic mechanisms underlying beta cell regeneration in the adult as a basis for producing new cellular therapies for diabetes. The BCBC will be responsible for collaboratively generating necessary reagents, mouse strains, antibodies, assays, protocols, and technologies that are beyond the scope of any single research effort.
Federal Grant Title: | Beta Cell Biology Consortium (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DK-04-018 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Endocrinology and Metabolism Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Nov 19, 2004 |
Posted Date: | Jun 28, 2004 |
Creation Date: | Jun 28, 2004 |
Archive Date: | Dec 19, 2004 |
Total Program Funding: | |
Maximum Federal Grant Award: | $500,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial...
- • Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial...
- • Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortiu...
- • Diabetes Research Centers (P30 Clinical Trial Optional)
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...